Skip to main content
. 2020 Aug 17;39(12):2289–2297. doi: 10.1007/s10096-020-04010-7

Table 4.

Detection rates of total antibodies (IgM/IgG) with Sienna® and Wondfo® in the two groups of patients among the three different stages

Healthcare workers Patients admitted to the Emergency Department
Sienna® (n = 93) Wondfo® (n = 93) Sienna® (n = 49) Wondfo® (n = 21)
IgM/IgG IgM/IgG IgM/IgG IgM/IgG
Early stage 14/61 (22.9%) 8/61 (13.1%) 5/6 (83.3%) 2/2 (100%)
Intermediate stage 10/18 (55.5%) 10/18 (55.5%) 33/39 (84.6%) 15/18 (83.3%)
Late stage 8/14 (57.1%) 5/14 (35.7%) 4/4 (100%) 1/1 (100%)
Total 32/93 (34.4%) 23/93 (24.7%) 42/49 (85.7%) 18/21 (85.7%)